News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Truong Vu
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/15/2023 |
4
| Truong Vu (CEO and Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.
Txns:
| Granted 100,000 options
@ $0.16, valued at
$16k
Exercised 15,000 restricted stock units
@ $0 |
|
12/07/2022 |
4
| Truong Vu (CEO) has filed a Form 4 on Aridis Pharmaceuticals, Inc.
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/06/2020 |
4
| Truong Vu (CEO and Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.
Txns:
| Exercised 50,000 options
@ $5.24, valued at
$262k
|
|
08/29/2019 |
4/A
| Truong Vu (CEO, CSO and Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.
Txns:
| Granted 200,000 options
@ $0 |
|
08/29/2019 |
3/A
| Truong Vu (CEO, CSO, Director) has filed a Form 3/A on Aridis Pharmaceuticals, Inc. |
03/13/2019 |
4
| Truong Vu (CEO and Director) has filed a Form 4 on Aridis Pharmaceuticals, Inc.
Txns:
| Granted 200,000 options
@ $8.46, valued at
$1.7M
|
|
08/13/2018 |
3
| Truong Vu (CEO, CSO, Director) has filed a Form 3 on Aridis Pharmaceuticals, Inc. |
|
|